Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea.
Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Korea.
Cells. 2021 Jun 11;10(6):1463. doi: 10.3390/cells10061463.
This study aims to obtain sufficient corneal endothelial cells for regenerative application. We examined the combinatory effects of Rho-associated kinase (ROCK) inhibitor Y-27632 and mesenchymal stem cell-derived conditioned medium (MSC-CM) on the proliferation and senescence of rabbit corneal endothelial cells (rCECs). rCECs were cultured in a control medium, a control medium mixed with either Y-27632 or MSC-CM, and a combinatory medium containing Y-27632 and MSC-CM. Cells were analyzed for morphology, cell size, nuclei/cytoplasmic ratio, proliferation capacity and gene expression. rCECs cultured in a combinatory culture medium showed a higher passage number, cell proliferation, and low senescence. rCECs on collagen type I film showed high expression of tight junction. The cell proliferation marker Ki-67 was positively stained either in Y-27632 or MSC-CM-containing media. Genes related to cell proliferation resulted in negligible changes in MKI67, CIP2A, and PCNA in the combinatory medium, suggesting proliferative capacity was maintained. In contrast, all of these genes were significantly downregulated in the other groups. Senescence marker β-galactosidase-positive cells significantly decreased in either MSC-CM and/or Y-27632 mixed media. Senescence-related genes downregulated LMNB1 and MAP2K6, and upregulated MMP2. Cell cycle checkpoint genes such as CDC25C, CDCA2, and CIP2A did not vary in the combinatory medium but were significantly downregulated in either ROCK inhibitor or MSC-CM alone. These results imply the synergistic effect of combinatory culture medium on corneal endothelial cell proliferation and high cell number. This study supports high potential for translation to the development of human corneal endothelial tissue regeneration.
本研究旨在获得足够的角膜内皮细胞用于再生应用。我们研究了 Rho 相关激酶(ROCK)抑制剂 Y-27632 和间充质干细胞来源的条件培养基(MSC-CM)对兔角膜内皮细胞(rCEC)增殖和衰老的协同作用。rCEC 分别在对照培养基、含有 Y-27632 或 MSC-CM 的对照培养基和含有 Y-27632 和 MSC-CM 的组合培养基中培养。分析细胞形态、细胞大小、核/细胞质比、增殖能力和基因表达。在组合培养物中培养的 rCEC 显示出更高的传代数、细胞增殖和低衰老。在 I 型胶原膜上的 rCEC 显示出紧密连接的高表达。Ki-67 是细胞增殖的标志物,在含有 Y-27632 或 MSC-CM 的培养基中均呈阳性染色。与细胞增殖相关的基因在组合培养基中导致 MKI67、CIP2A 和 PCNA 的变化可以忽略不计,这表明增殖能力得到维持。相比之下,在其他组中,这些基因均显著下调。在 MSC-CM 和/或 Y-27632 混合培养基中,衰老标志物β-半乳糖苷酶阳性细胞显著减少。衰老相关基因下调 LMNB1 和 MAP2K6,并上调 MMP2。细胞周期检查点基因如 CDC25C、CDCA2 和 CIP2A 在组合培养基中没有变化,但在 ROCK 抑制剂或 MSC-CM 单独使用时显著下调。这些结果表明组合培养物对角膜内皮细胞增殖和高细胞数的协同作用。本研究支持将其转化为开发人眼角膜内皮组织再生的高潜力。